Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Claudia Pfensig"'
Autor:
Alexandra Rivera Luna, Hartmut Schmidt, Hans Ulrich Gerth, Claudia Pfensig, Jan Stange, Christoph Sponholz, Sebastian Klammt, Christian Wilms, Kristin Bruederlein, Andreas Kortgen, Michael Hinz, Steffen Mitzner, Matthias M. Dollinger, Raoul Benedikt Sauer, Victoria Rivera Luna, Adrian Dominik, Sebastian Koball
Publikováno v:
Gastroenterology: Medicine & Research. 4
Autor:
Badr Ibrahim, Matthias Suraj, Claudia Pfensig, Martin Eggert, Adrian Dominik, Jan Stange, Anja K Baumann
Publikováno v:
Therapeutic Apheresis and Dialysis. 22:196-204
Liver failure results in impaired hepatic detoxification combined with diminished albumin synthesis and is associated with secondary organ failure. The accumulation of liver toxins has shown to saturate albumin binding sites. This was previously demo
Publikováno v:
Artificial Organs. 40:397-402
Albumin dialysis in extracorporeal organ support is often performed in the treatment of liver failure as it facilitates the removal of toxic components from the blood. Here, we describe a possible effect of albumin dialysis on proinflammatory cytokin
Autor:
Adrian, Dominik, Jan, Stange, Anja K, Baumann, Claudia, Pfensig, Matthias, Suraj, Badr, Ibrahim, Martin, Eggert
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 22(2)
Liver failure results in impaired hepatic detoxification combined with diminished albumin synthesis and is associated with secondary organ failure. The accumulation of liver toxins has shown to saturate albumin binding sites. This was previously demo
Autor:
Jan Stange, Claudia Pfensig, Martin Eggert, Helga Weiss-Reining, Luise Borufka, Adrian Dominik
Publikováno v:
Therapeutic Apheresis and Dialysis. 18:347-352
The removal of small water soluble toxins and albumin-bound toxins in acute liver failure patients (ALF) or acute-on-chronic liver failure (AocLF) patients has been established using extracorporeal liver support devices (e.g. Molecular Adsorbents Rec
Autor:
Adrian, Dominik, Jan, Stange, Claudia, Pfensig, Luise, Borufka, Helga, Weiss-Reining, Martin, Eggert
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 18(4)
The removal of small water soluble toxins and albumin-bound toxins in acute liver failure patients (ALF) or acute-on-chronic liver failure (AocLF) patients has been established using extracorporeal liver support devices (e.g. Molecular Adsorbents Rec